CLINICAL_TRIALS
trial_result
· 2023-06-06
Clinical Trial Update: Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain [Phase 2]
Summary
Phase 2 trial update on ETX-018810 for lumbosacral radicular pain reports efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eliem Therapeutics (UK) Ltd. | Conditions: Lumbosacral Radiculopathy | Phase 2 | Status: COMPLETED | Results posted: 2023-06-06